The DOI matches its Crossref record; 26 of the 26 references it cites were found in a registry or an index.
Prognostic Value of Troponin T and I Among Asymptomatic Patients With End-Stage Renal Disease: A Meta-Analysis
Abstract
Background— The prognostic usefulness of troponin enzymes in end-stage renal disease (ESRD) patients is controversial. To resolve this uncertainty of troponin as a prognostic tool, we conducted a systematic review to quantify the association between elevated troponin I or T and long-term total mortality among ESRD patients not suspected of having acute coronary syndrome. Methods and Results— We conducted an unrestricted search from the MEDLINE, EMBASE, and DARE bibliographic databases to December 2004 using the terms troponin.mp. or exp troponin and exp kidney, exp renal, exp kidney disease exp renal replacement therapy . We also manually searched review articles and bibliographies to supplement the search. Studies were included if they were prospective observational studies, used cardiac-specific troponin assays, and evaluated long-term risk of death or cardiac events for asymptomatic ESRD patients. Two authors independently abstracted data on study and patient characteristics. Studies findings were stratified according to troponin T or I levels. We used a random-effects model to pool study results and tested for heterogeneity using χ 2 testing and used funnel-plot inspection to evaluate the presence of publication bias. Data from 28 studies (3931 patients) published between 1999 and December 2004 were included in this review. Patients received dialysis for a median duration of 4 years, with a mean follow-up of 23 months. From the pooled analysis, elevated troponin T (>0.1 ng/mL) was significantly associated with increased all-cause mortality (relative risk, 2.64; 95% CI, 2.17 to 3.20). Although the prognostic effect sizes were all consistent with a positive relationship between troponin T and mortality, there was significant heterogeneity in the magnitude of these effect sizes ( P =0.015). The funnel plot showed evidence of publication bias. Elevated troponin T was also strongly associated with increased cardiac death. Studies evaluating troponin I included a wide variety of assays and differing cut points, rendering synthesis of the study findings difficult. Conclusions— Elevated troponin T (>0.1 ng/mL) identifies a subgroup of ESRD patients who have poor survival and a high risk of cardiac death despite being asymptomatic. These findings suggest that troponin T is a promising risk stratification tool and may help frame therapeutic decisions. The clinical interpretation of elevated troponin I levels, however, remain unclear, largely because of the lack of standardization of assays.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Meta-analysis of Observational Studies in Epidemiology<SUBTITLE>A Proposal for Reporting</SUBTITLE>
Stroup, D. F. (2000) · JAMA · doi:10.1001/jama.283.15.2008 · Cited by 20,623
Systematic Reviews in Health Care: Meta‐Analysis in Context
(2001) · doi:10.1002/9780470693926 · Cited by 1,693
Cardiac Troponin T Levels for Risk Stratification in Acute Myocardial Ischemia
Ohman, E. M., Armstrong, P. W., Christenson, R. H., Granger, C. B., Katus, H. A., Hamm, C. W., O’Hanesian, M. A., Wagner, G. S., Kleiman, N. S., Harrell, F. E., et al. (1996) · New England Journal of Medicine · doi:10.1056/nejm199610313351801 · Cited by 1,114
Poor Long-Term Survival after Acute Myocardial Infarction among Patients on Long-Term Dialysis
Herzog, C. A., Ma, J. Z., & Collins, A. J. (1998) · New England Journal of Medicine · doi:10.1056/nejm199809173391203 · Cited by 885
Predictive Value of Cardiac Troponin I and T for Subsequent Death in End-Stage Renal Disease
Apple, F. S., Murakami, M. M., Pearce, L. A., & Herzog, C. A. (2002) · Circulation · doi:10.1161/01.cir.0000041254.30637.34 · Cited by 559
Cardiac troponins in renal insufficiency
Freda, B. J., Tang, W. H. W., Van Lente, F., Peacock, W. F., & Francis, G. S. (2002) · Journal of the American College of Cardiology · doi:10.1016/s0735-1097(02)02608-6 · Cited by 414
Apple, F. S., Wu, A. H. B., & Jaffe, A. S. (2002) · American Heart Journal · doi:10.1067/mhj.2002.124048 · Cited by 397
Evaluation of Imprecision for Cardiac Troponin Assays at Low-Range Concentrations
Panteghini, M., Pagani, F., Yeo, K.-T. J., Apple, F. S., Christenson, R. H., Dati, F., Mair, J., Ravkilde, J., Wu, A. H. B., & the Committee on Standardization of Markers of Cardiac Damage of the IFCC (2004) · Clinical Chemistry · doi:10.1373/clinchem.2003.026815 · Cited by 368
Troponin T Levels in Patients with Acute Coronary Syndromes, with or without Renal Dysfunction
Aviles, R. J., Askari, A. T., Lindahl, B., Wallentin, L., Jia, G., Ohman, E. M., Mahaffey, K. W., Newby, L. K., Califf, R. M., Simoons, M. L., et al. (2002) · New England Journal of Medicine · doi:10.1056/nejmoa013456 · Cited by 345
Apple, F. S., Quist, H. E., Doyle, P. J., Otto, A. P., & Murakami, M. M. (2003) · Clinical Chemistry · doi:10.1373/49.8.1331 · Cited by 322
Bodor, G. S., Porterfield, D., Voss, E. M., Smith, S., & Apple, F. S. (1995) · Clinical Chemistry · doi:10.1093/clinchem/41.12.1710 · Cited by 311
Ricchiuti, V., Voss, E. M., Ney, A., Odland, M., Anderson, P. A. W., & Apple, F. S. (1998) · Clinical Chemistry · doi:10.1093/clinchem/44.9.1919 · Cited by 208
Cardiac Troponin T and I in End-Stage Renal Failure
Wayand, D., Baum, H., Schätzle, G., Schärf, J., & Neumeier, D. (2000) · Clinical Chemistry · doi:10.1093/clinchem/46.9.1345 · Cited by 178
Mapping-guided ablation of pulmonary veins to cure atrial fibrillation
Haı̈ssaguerre, M., Shah, D. C., Jaı̈s, P., Hocini, M., Yamane, T., Deisenhofer, I., Garrigue, S., & Clémenty, J. (2000) · The American Journal of Cardiology · doi:10.1016/s0002-9149(00)01186-3 · Cited by 158
Roppolo, L. P., Fitzgerald, R. L., Dillow, J. M., Ziegler, T. W., Rice, M., & Maisel, A. (1999) · Journal of the American College of Cardiology · doi:10.1016/s0735-1097(99)00207-7 · Cited by 108
Cardiac troponin elevations in chronic renal failure: prevalence and clinical significance
Musso, P., Cox, I. D., Vidano, E., Zambon, D., & Panteghini, M. (1999) · Clinical Biochemistry · doi:10.1016/s0009-9120(98)00089-7 · Cited by 99
Hocher, B., Ziebig, R., Altermann, C., Krause, R., Asmus, G., Richter, C.-M., Slowinski, T., Sinha, P. K., & Neumayer, H. (2003) · Journal of the American Society of Nephrology · doi:10.1097/01.asn.0000081662.64171.9b · Cited by 63
Khan, I. A., Wattanasuwan, N., Mehta, N. J., Tun, A., Singh, N., Singh, H. K., Vasavada, B. C., & Sacchi, T. J. (2001) · Journal of the American College of Cardiology · doi:10.1016/s0735-1097(01)01513-3 · Cited by 62
Aronow, W. S., Ahn, C., Mercando, A. D., & Epstein, S. (2000) · The American Journal of Cardiology · doi:10.1016/s0002-9149(00)01176-0 · Cited by 57
Ooi, D. S., Veinot, J. P., Wells, G. A., & House, A. A. (1999) · Clinical Biochemistry · doi:10.1016/s0009-9120(99)00064-8 · Cited by 54
Ishii, J., Nomura, M., Okuma, T., Minagawa, T., Naruse, H., Mori, Y., Ishikawa, T., Kurokawa, H., Hirano, T., Kondo, T., et al. (2001) · Clinica Chimica Acta · doi:10.1016/s0009-8981(01)00592-7 · Cited by 53
Löwbeer, C., Gustafsson, S. A., Seeberger, A., Bouvier, F., & Hulting, J. (2004) · Scandinavian Journal of Clinical and Laboratory Investigation · doi:10.1080/00365510410003002 · Cited by 49
Nakamura, S., Uzu, T., Inenaga, T., & Kimura, G. (2000) · American Journal of Kidney Diseases · doi:10.1053/ajkd.2000.16198 · Cited by 45
Hocher, B., Ziebig, R., Krause, R., et al. (2004) · Circulation · doi:10.1161/01.cir.0000128598.72920.b5 · Cited by 30
Cardiac Troponin T Is Not Detected in Western Blots of Diseased Renal Tissue
Davis, G. K., Labugger, R., Eyk, J. E. V., & Apple, F. S. (2001) · Clinical Chemistry · doi:10.1093/clinchem/47.4.782 · Cited by 25
Cited by
Hemodialysis-Induced Cardiac Injury: Determinants and Associated Outcomes
Burton, J. O., Jefferies, H. J., Selby, N. M., & McIntyre, C. W. (2009) · Clinical Journal of the American Society of Nephrology · doi:10.2215/cjn.03900808 · Cited by 686
Recommendations for the use of cardiac troponin measurement in acute cardiac care
Thygesen, K., Mair, J., Katus, H., Plebani, M., Venge, P., Collinson, P., Lindahl, B., Giannitsis, E., Hasin, Y., Galvani, M., et al. (2010) · European Heart Journal · doi:10.1093/eurheartj/ehq251 · Cited by 628
Cardiac troponins: from myocardial infarction to chronic disease
Park, K. C., Gaze, D. C., Collinson, P. O., & Marber, M. S. (2017) · Cardiovascular Research · doi:10.1093/cvr/cvx183 · Cited by 510
Newby, L. K., Jesse, R. L., Babb, J. D., Christenson, R. H., De Fer, T. M., Diamond, G. A., Fesmire, F. M., Geraci, S. A., Gersh, B. J., Larsen, G. C., et al. (2012) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2012.08.969 · Cited by 402
Cardiac Disease Evaluation and Management Among Kidney and Liver Transplantation Candidates
Lentine, K. L., Costa, S. P., Weir, M. R., Robb, J. F., Fleisher, L. A., Kasiske, B. L., Carithers, R. L., Ragosta, M., Bolton, K., Auerbach, A. D., et al. (2012) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2012.05.008 · Cited by 399
Metadata
- Authors
- Khan, N. A., Hemmelgarn, B. R., Tonelli, M., Thompson, C. R., & Levin, A.
- Venue
- Circulation
- Published
- 2005-11-15
- Volume
- 112
- Issue
- 20
- Pages
- 3088-3096
- ISSN
- 0009-7322 (ISSN-L)
- 1524-4539
- OpenAlex
- W2066955790
- Cited by
- 351
- References
- 26
- FWCI
- 11.04
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.